This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Research and anecdotal reports have already displayed that cannabis can be used to treat the symptoms of migraines. However, there has not been a clinicaltrial assessing the efficacy of cannabis for migraines, at least not until now. The First ClinicalTrial for Migraines and Cannabis.
Though the Canada-based authors conclude that transdermal delivery of CBD shows great promise and represents a potential novel treatment for chronic inflammatory pain, they also acknowledge that the jury is still out on its ability to achieve that key benchmark of offering tangible clinical benefits. The findings are mixed.
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Here’s what they found.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
to develop and manufacture soft gel capsules of Incannex’s cannabis medicine IHL-42X. The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinicaltrials. According to an article from the Lancet, sleep apnea affects 936 million adults globally.
If you want to learn how cannabinoids—special parts of the cannabis plant—might help, you’re in the right place. Cannabinoids are special chemicals found in the cannabis plant. There are three main types: the ones in plants (like cannabis), the ones our bodies make, and some that scientists create in labs. That’s a huge number!
The clinicaltrials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. Within the past 30 years, there has been an increase in substantial research which supports cannabis as a medical intervention.
But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. Nor is it necessarily surprising, given the ability of cannabis to target the ubiquitous, homeostasis-seeking endocannabinoid system. It’s not a new idea.
For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.
PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy ClinicalTrial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.
A new study concludes that PlusCBD Oil supplements can help improve sleep, support reduction in appetite and help enhance quality of life in humans. . Did you know sleep deficiency is a pretty common health issue in the United States? RELATED: I’m A Business Owner Who Uses Cannabis & CBD For Anxiety.
Published in Cannabis and Cannabinoid Research in late September, the survey found that the majority of respondents reported that their health conditions were “very much improved” or “much improved” by the use of CBG. No clinicaltrial was used in the compilation of the study. who have used it to treat anxiety.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.
This transcript is adapted from CannMed’s weekly podcast , hosted by Ben Amirault, who recently interviewed Bonni Goldstein, MD, one of the country’s most respected and experienced medical cannabis physicians. Dr. Goldstein has treated thousands of patients with medical cannabis. CBG is not intoxicating or impairing.
Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.
If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Virtual ClinicalTrials transcend geographic, mobility and economic barriers. Authored By : Arundati Dandapani.
Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.” What Is Microdosing Cannabis?
The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. Of those who have used cannabis, most did not receive a recommendation from a doctor or instructions on how to use it, according to the findings of a recent study.
As if those weren’t enough, the fear of the virus alone can also wreak havoc on sleep patterns. Patients around the world are reporting a sharp increase in sleep problems, and physicians have coined the term coronasomnia to describe the phenomenon. A team of researchers is studying the coronavirus-era sleep crisis.
Like many people who are drawn to work with and advocate for medical cannabis , I first saw the difference that cannabis can make with someone very close to me. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis. Transfering nurses’ skills to cannabis medicine.
Cannabis and the Immune System. Cannabis and the Immune System. In fact, cannabis has been used for thousands of years as a medicine. Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Immune System and Sleep Deprivation. Introduction.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms. In addition, cannabis users participating in the survey were younger by an average of 3 years in age than non-users in the survey. Why Do Parkinson’s Patients Use Marijuana?
In the world of cannabis, not everyone can be Snoop, Seth Rogen, or Willie Nelson. There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. I also take a chewy (cannabis pill) at bedtime and this has really helped, too.”. 1) Patrick Stewart. 3) Steve Kerr.
Top 6 ways that Medical Marijuana helps patients with PTSD or other anxiety and mood disorders: Anxiety and Fear Reduction: THC (tetrahydrocannabinol) and CBD (cannabidiol) are the primary cannabinoids in cannabis that interact with the body’s own endocannabinoid system , which plays a role in regulating mood, fear, and stress responses.
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Study Offers Insight Into Adult Athletes’ Relationship to Cannabis and its Potential for Pain Management. July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes.
With over 100 potent cannabinoids that constitute the Cannabis plant, the possibilities of health benefits are ample. The growth in the cannabis industry has promoted interest among users of several segments to understand how it can make their lives better. Aids with Sleep. Aids in Pain Management.
Study Offers Insight Into Adult Athletes’ Relationship to Cannabis and its Potential for Pain Management. July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes.
Additionally, the ACPA reported on a clinicaltrial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. For centuries, humans have relied on the cannabis plant for its therapeutic properties. anxiety, chronic pain; and yield different side effects associated with cannabis use.
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable ClinicalTrials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinicaltrials in the areas of psychedelics and nutraceuticals, among other substances of study.
Cannabis and opioid medications both produce analgesic effects. Researchers who recently published a survey they conducted, wanted to see whether medical cannabis has an effect on the usage of or even possibly replace opioid medications. The Effect of Medical Cannabis on Prescription Opioids. America’s Cannabis Catch-22.
Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.
-1000s of UK athletes regularly taking CBD to manage pain, sleep disorders and anxiety – -Football, Rugby, Cricket, Hockey and Golf stars want clarity from governing bodies-. -UK UK sport has opportunity to lead the world-.
Prominent health organizations acknowledge the benefits and lack of side effects of using medical cannabis for controlling chronic pain Chronic pain is widely accepted by the medical community to signify disease itself, which can be made much worse by environmental and psychological factors.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Because cannabis is still a schedule 1 drug in the U.S., clinical research is extremely difficult to conduct. So far, science is telling us that yes cannabis has anti-seizure actions.
Both IBD and IBS have a major impact on the quality of life and on the ability to do simple things such as eat, sleep, and work. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Cannabis for GI Pathologies . What is IBD?
For many who were young in the 1960s and 70s, cannabis was something seen at parties, possibly experimented with, but for the most part set aside. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Here, too, cannabis has been shown to have a distinct effect.
Cannabis use disorder (CUD) is often confused with frequent cannabis use , but CUD is significantly more worrisome. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. ClinicalTrial Sample Size.
Legal cannabis consumption and it isn’t even legal yet. If and when cannabis is actually properly regulated we’re sure the UK can be a world beater!! Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis.
(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain.
First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. Medicinal cannabis as a last resort.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content